Contact us
QuantiFERON® SARS-CoV-2 for COVID-19 T-cell response
Note: Only available in Scandinavia
Valuable insights into our immune system’s response to COVID-19
Studies suggest that T-cell response to SARS-CoV-2 declines much more slowly than antibody response, which presents several benefits to researchers who want to push beyond the existing detection of active infections to screen for potential courses of the illness and long-term immune responses to it.
Studies show growing evidence that T-cell response gives a reliable indication of how severe the course of an illness triggered by SARS-CoV-2 will be in infected patients, and how immune those who have recovered remain months – possibly even years – after having been infected.
QuantiFERON® SARS-CoV-2 is a flexible, modular system designed to meet a wide range of research demands. It is based on QIAGEN’s easy-to-use QuantiFERON® technology, pioneered in the QuantiFERON® -TB Gold Plus test for latent tuberculosis and recognized worldwide for its ability to detect interferon gamma that T-cells release upon contact with certain pathogens.
T-cell detection
- T-cell response to SARS-CoV-2 may decline less rapidly than antibodies
- T-cell response has the potential to give a clearer picture of immunity and course of illness
| Item number | Product name |
|---|---|
| 10801 | QF SARS-CoV-2 Starter Set BCT(50) Ref. 626725 |
| 10081 | QFN Elisa – ref. 626410 |
Get in touch
If you have any questions, comments, or collaboration inquiries, you are very welcome to reach out.
Please fill in the form and we will get back to you as soon as possible.